Takeuchi T, Tanaka S, Murata M, Tanaka Y, et al. Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial. Ann Rheum Dis 2023 May 22:ard-2022-223759. doi: 10.1136/ard-2022-223759.
PMID: 37217273